Editas Medicine Inc

Stock Chart, Company Information, and Scan Results

$3.50(as of Sep 29, 3:58 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Editas Medicine Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$3.50
Ticker SymbolEDIT
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees246
CountyUSA
Market Cap$291.3M

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Editas Medicine Inc In Our Stock Scanner

As of Sep 30, 2025
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.